REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 137 filers reported holding REVANCE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,630,814 | -47.8% | 1,023,663 | 0.0% | 0.01% | -38.5% |
| Q1 2024 | $5,036,422 | -44.0% | 1,023,663 | 0.0% | 0.01% | -45.8% |
| Q4 2023 | $8,997,998 | -23.1% | 1,023,663 | +0.3% | 0.02% | -29.4% |
| Q3 2023 | $11,702,084 | -58.8% | 1,020,234 | -9.1% | 0.03% | -57.0% |
| Q2 2023 | $28,414,676 | -17.5% | 1,122,666 | +5.0% | 0.08% | -23.3% |
| Q1 2023 | $34,448,047 | +48.4% | 1,069,483 | -15.0% | 0.10% | +32.1% |
| Q4 2022 | $23,217,290 | -50.0% | 1,257,708 | -26.9% | 0.08% | -48.0% |
| Q3 2022 | $46,454,000 | +99.7% | 1,720,508 | +2.2% | 0.15% | +100.0% |
| Q2 2022 | $23,259,000 | -14.3% | 1,683,008 | +20.9% | 0.08% | +11.9% |
| Q1 2022 | $27,152,000 | +19.5% | 1,392,408 | 0.0% | 0.07% | +39.6% |
| Q4 2021 | $22,724,000 | -41.4% | 1,392,408 | 0.0% | 0.05% | -45.5% |
| Q3 2021 | $38,792,000 | +15.4% | 1,392,408 | +22.8% | 0.09% | +14.3% |
| Q2 2021 | $33,610,000 | +10.1% | 1,133,932 | +3.9% | 0.08% | +2.7% |
| Q1 2021 | $30,514,000 | +45.2% | 1,091,732 | +47.2% | 0.08% | +44.2% |
| Q4 2020 | $21,021,000 | +43.7% | 741,732 | +27.5% | 0.05% | +15.6% |
| Q3 2020 | $14,625,000 | +2.9% | 581,732 | 0.0% | 0.04% | -11.8% |
| Q2 2020 | $14,206,000 | +89.4% | 581,732 | +14.8% | 0.05% | +37.8% |
| Q1 2020 | $7,500,000 | -44.2% | 506,732 | -38.8% | 0.04% | -27.5% |
| Q4 2019 | $13,434,000 | +24.8% | 827,732 | 0.0% | 0.05% | +15.9% |
| Q3 2019 | $10,761,000 | +30.6% | 827,732 | +30.3% | 0.04% | +33.3% |
| Q2 2019 | $8,239,000 | +2.7% | 635,200 | +24.7% | 0.03% | -2.9% |
| Q1 2019 | $8,025,000 | +1190.2% | 509,200 | +1597.3% | 0.03% | +1600.0% |
| Q1 2015 | $622,000 | -14.6% | 30,000 | -30.2% | 0.00% | -33.3% |
| Q4 2014 | $728,000 | -12.4% | 43,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $831,000 | +22.2% | 43,000 | +115.0% | 0.00% | 0.0% |
| Q2 2014 | $680,000 | +23.4% | 20,000 | +14.3% | 0.00% | +50.0% |
| Q1 2014 | $551,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NQ HCIF GP, Ltd. | 3,096,650 | $52,457,000 | 100.00% |
| Essex Woodlands Management, Inc. | 4,592,047 | $77,789,000 | 24.28% |
| Rhenman & Partners Asset Management AB | 126,574 | $2,144,000 | 0.62% |
| Polar Capital LLP | 1,107,272 | $18,756,000 | 0.37% |
| ArrowMark Colorado Holdings LLC | 787,923 | $13,347,000 | 0.34% |
| Lombard Odier Asset Management (USA) Corp | 250,605 | $4,245,000 | 0.29% |
| Visium Asset Management, LP | 1,000,000 | $16,940,000 | 0.24% |
| C Partners Holding GmbH | 24,000 | $407,000 | 0.13% |
| NOTTINGHAM ADVISORS, INC. | 23,018 | $390,000 | 0.10% |
| WALL STREET ASSOCIATES | 57,330 | $971,000 | 0.09% |